企業プロフィール
Armata Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- ARMP
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
5.10 USD (+15.38%)
終値
最終更新: 2026年8月21日
291M USD
時価総額
株価変動の要因
As of Aug 21, 2026, ARMP closed up 15.4% at $5.10. No new same-company headline was identified in the current news window.
企業概要
事業概要
Armata Pharmaceuticals is a bacteriophage company focused on precision therapies for bacterial infections. Its platform aims to use phage biology to address resistant pathogens.
所在地とセクター分類
Headquartered in the United States and listed on NYSE American, Armata sits in specialty biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, anti-infective differentiation, and the ability to build a durable phage-therapy story.
バイオ業界での位置付け
Armata is a niche anti-infective catalyst name whose valuation depends on development progress.
今後のカタリスト
- Armata’s catalysts are phage-therapy programs, especially any update that shows the antibacterial platform can keep progressing. The market will care about whether the clinical path stays open.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。